BioCardia outlines design of CardiAMP HF II heart failure trial at HFSA 2026 meeting

BCDA•2026-10-07

BioCardia said a poster detailing the CardiAMP HF II trial design is scheduled for the October 9–12 HFSA 2026 meeting in Phoenix; results have not been presented.

BioCardia outlines design of CardiAMP HF II heart failure trial at HFSA 2026 meeting

1. Trial design poster

Related News

Marriott signs deal with FICO to add 1,262 hotel keys across Thailand

Nasdaq pauses trading in SMXT for volatility at 9:35 a.m.

Nasdaq trade halt: volatility trading pause at 09:38 am

Alaska Air schedules quarterly call on third-quarter 2026 results

Morningstar launches Direct AI agentic platform for investment professionals